JPH01118530A - Molded item of fibroin and its preparation - Google Patents
Molded item of fibroin and its preparationInfo
- Publication number
- JPH01118530A JPH01118530A JP27784387A JP27784387A JPH01118530A JP H01118530 A JPH01118530 A JP H01118530A JP 27784387 A JP27784387 A JP 27784387A JP 27784387 A JP27784387 A JP 27784387A JP H01118530 A JPH01118530 A JP H01118530A
- Authority
- JP
- Japan
- Prior art keywords
- fibroin
- molded product
- crosslinking agent
- water
- soln
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108010022355 Fibroins Proteins 0.000 title claims abstract description 90
- 239000003431 cross linking reagent Substances 0.000 claims abstract description 18
- 239000012528 membrane Substances 0.000 claims abstract description 9
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 claims abstract description 5
- 239000000835 fiber Substances 0.000 claims abstract description 5
- 238000000465 moulding Methods 0.000 claims abstract description 4
- 238000004519 manufacturing process Methods 0.000 claims description 8
- 239000011325 microbead Substances 0.000 claims description 4
- VPKDCDLSJZCGKE-UHFFFAOYSA-N carbodiimide group Chemical group N=C=N VPKDCDLSJZCGKE-UHFFFAOYSA-N 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 16
- 238000000034 method Methods 0.000 abstract description 11
- 238000000502 dialysis Methods 0.000 abstract description 6
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 abstract description 4
- 108010013296 Sericins Proteins 0.000 abstract description 4
- 239000002994 raw material Substances 0.000 abstract description 4
- 125000005442 diisocyanate group Chemical group 0.000 abstract description 3
- 238000001035 drying Methods 0.000 abstract description 3
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 abstract description 2
- 239000002473 artificial blood Substances 0.000 abstract description 2
- 210000004204 blood vessel Anatomy 0.000 abstract description 2
- 238000011033 desalting Methods 0.000 abstract description 2
- 229910001628 calcium chloride Inorganic materials 0.000 abstract 1
- 239000001110 calcium chloride Substances 0.000 abstract 1
- 229960000587 glutaral Drugs 0.000 abstract 1
- 238000007670 refining Methods 0.000 abstract 1
- 238000009958 sewing Methods 0.000 abstract 1
- 239000000047 product Substances 0.000 description 22
- 239000007864 aqueous solution Substances 0.000 description 15
- 239000000243 solution Substances 0.000 description 11
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide Substances CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 8
- 239000013078 crystal Substances 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 4
- AMXOYNBUYSYVKV-UHFFFAOYSA-M lithium bromide Chemical compound [Li+].[Br-] AMXOYNBUYSYVKV-UHFFFAOYSA-M 0.000 description 4
- 229920001059 synthetic polymer Polymers 0.000 description 4
- 239000002699 waste material Substances 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 150000001718 carbodiimides Chemical group 0.000 description 3
- 238000002425 crystallisation Methods 0.000 description 3
- 230000008025 crystallization Effects 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- ZCCIPPOKBCJFDN-UHFFFAOYSA-N calcium nitrate Chemical compound [Ca+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O ZCCIPPOKBCJFDN-UHFFFAOYSA-N 0.000 description 2
- 238000007385 chemical modification Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 238000004132 cross linking Methods 0.000 description 2
- 239000003937 drug carrier Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- YIXJRHPUWRPCBB-UHFFFAOYSA-N magnesium nitrate Chemical compound [Mg+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O YIXJRHPUWRPCBB-UHFFFAOYSA-N 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000009210 therapy by ultrasound Methods 0.000 description 2
- DCESWPKOLYIMNH-UHFFFAOYSA-N 2-(2,5-dioxopyrrolidin-1-yl)propanoic acid Chemical compound OC(=O)C(C)N1C(=O)CCC1=O DCESWPKOLYIMNH-UHFFFAOYSA-N 0.000 description 1
- 244000186140 Asperula odorata Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 239000004593 Epoxy Chemical class 0.000 description 1
- 235000008526 Galium odoratum Nutrition 0.000 description 1
- 108010093096 Immobilized Enzymes Proteins 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 238000000944 Soxhlet extraction Methods 0.000 description 1
- YUUKIOKWOBAUSK-UHFFFAOYSA-L [OH-].[OH-].[Cu+2].NCCN Chemical compound [OH-].[OH-].[Cu+2].NCCN YUUKIOKWOBAUSK-UHFFFAOYSA-L 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- QKSIFUGZHOUETI-UHFFFAOYSA-N copper;azane Chemical compound N.N.N.N.[Cu+2] QKSIFUGZHOUETI-UHFFFAOYSA-N 0.000 description 1
- 239000012024 dehydrating agents Substances 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000004088 foaming agent Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- CTAPFRYPJLPFDF-UHFFFAOYSA-N isoxazole Chemical class C=1C=NOC=1 CTAPFRYPJLPFDF-UHFFFAOYSA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 238000010647 peptide synthesis reaction Methods 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000009991 scouring Methods 0.000 description 1
- 229910001961 silver nitrate Inorganic materials 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 238000009987 spinning Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 239000013076 target substance Substances 0.000 description 1
- 238000009864 tensile test Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Manufacture Of Macromolecular Shaped Articles (AREA)
- Treatments Of Macromolecular Shaped Articles (AREA)
- Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
Abstract
Description
【発明の詳細な説明】
〈産業上の利用分野〉
本発明は、伸縮性、柔軟性にすぐれ、さらに生体親和性
にもすぐれるフィブロイン成形物およびその製造方法に
関する。DETAILED DESCRIPTION OF THE INVENTION <Industrial Application Field> The present invention relates to a fibroin molded product that has excellent stretchability, flexibility, and biocompatibility, and a method for producing the same.
〈従来の技術〉
従来、絹糸は、肌ざわり、風合い、光沢のよい天然繊維
として衣料用用途に古代より用いられてきたが、近年そ
の主成分であるフィブロインは、成形可能な天然のタン
パク質として化粧用、医療用等の素材として用いられる
ようになった。 例えば、酵素含有膜(特開昭55−8
1589 ) 、固定酵素担体(特開昭56−1568
7)、多孔性膜(特開昭56−40156) 、固型芳
香剤(特開昭56−163658 ) 、親水性多孔体
(特開昭56−166235 ) 、パック剤(特開昭
57−77812)、ローション(特開昭57−175
11!1 ) 、吸水剤(特開昭58−244) 、パ
ップ剤(特開昭59−27821)、発泡体(特公昭5
9−21339) 、固定化抗体担体(特開昭80−1
42259 ) 、固定化抗原/抗体担体(特開昭60
−155129 )薬剤担体(特開昭6O−15512
5)、メイクアップ化粧i(特開昭62−415)、な
どにフィブロインは単独あるいは他の化合物と共に用い
られる。<Conventional technology> Silk thread has been used since ancient times for clothing as a natural fiber with good texture, texture, and luster, but in recent years its main component, fibroin, has been used in cosmetics as a moldable natural protein. It has come to be used as a material for industrial and medical purposes. For example, an enzyme-containing membrane (Japanese Patent Application Laid-Open No. 55-8
1589), immobilized enzyme carrier (JP-A-56-1568)
7), Porous membrane (JP-A-56-40156), solid fragrance (JP-A-56-163658), hydrophilic porous body (JP-A-56-166235), pack agent (JP-A-57-77812) ), lotion (JP-A-57-175
11!1), water-absorbing agents (Japanese Patent Publication No. 58-244), poultices (Japanese Patent Publication No. 59-27821), foams (Japanese Patent Publication No. 58-27821),
9-21339), immobilized antibody carrier (Japanese Patent Application Laid-Open No. 80-1989)
42259), immobilized antigen/antibody carrier (Japanese Patent Application Laid-open No. 1983
-155129) Drug carrier (JP-A-6O-15512
5), Make-up Cosmetics I (JP-A-62-415), etc. Fibroin is used alone or in combination with other compounds.
これらの用途に用いられるフィブロインは、まゆ、生糸
、まゆ屑、生糸屑等からセリシンを取り除き、アルカリ
金属、アルカリ土類金属を含む水溶液に溶かし、その後
透析等の方法で脱塩して得られるフィブロイン水溶液を
原料としている。The fibroin used for these purposes is obtained by removing sericin from cocoon, raw silk, cocoon waste, raw silk waste, etc., dissolving it in an aqueous solution containing alkali metals and alkaline earth metals, and then desalting it by a method such as dialysis. The raw material is an aqueous solution.
この水溶液フィブロインを単独または他の化合物と共に
所望の形態、性状に成形加工して目的物質を作製するわ
けであるが、いずれにせよ水溶性フィブロインを水不溶
性フィブロインに転移させなければならない。This aqueous fibroin alone or together with other compounds is molded into the desired form and properties to produce the target substance, but in any case, water-soluble fibroin must be transferred to water-insoluble fibroin.
そのための方法の一つとして、結晶化度を上げる処理が
行なわれていた。 す なわ ち、フィブロインの分子
形態としては、 randomcoil、5ilk I
型結晶(α型構造) 、 5ilkll型結晶(β型構
造)が知られているが(0,Kratky。As one method for this purpose, treatment to increase the degree of crystallinity has been carried out. In other words, the molecular forms of fibroin are random coil, 5ilk I
Type crystals (α type structure) and 5ilkll type crystals (β type structure) are known (0, Kratky).
et、al、 Nature、165.475(195
0)、5ilk II型結晶以外は水溶性であるため、
何らかの手段で5ilkII型結晶の結晶化分率を上げ
て水不溶化しなけらばならない。et, al, Nature, 165.475 (195
0), 5ilk Since all crystals other than type II crystals are water-soluble,
The crystallization fraction of the 5ilkII type crystal must be increased by some means to make it insoluble in water.
その手段としては、例えばジオール類、多価アルコール
類等を添加する(特開昭55−81589)、低温凍結
乾燥する(特開昭56−40156)、pHを3.0〜
5.0にする、低級アルコールを添加する、速いズリ変
形速度で攪拌する、超音波処理を行う(以上特開昭56
−163658など)などの方法がある。Examples of such methods include adding diols, polyhydric alcohols, etc. (Japanese Unexamined Patent Publication No. 55-81589), freeze-drying at low temperature (Japanese Unexamined Patent Publication No. 56-40156), and adjusting the pH to 3.0 or more.
5.0, add lower alcohol, stir at high shear deformation speed, and perform ultrasonic treatment.
-163658, etc.).
また、結晶化度を上げるのではなく、用途に応じて合成
ポリマーをグラフトする(特開昭57−77612など
)、合成ポリマーと結合させる(特開昭58−244な
ど)、主成分のゴムにフィブロインを結合させる(特公
昭59−21339)などの方法も考えられる。In addition, instead of increasing the degree of crystallinity, depending on the application, synthetic polymers may be grafted (e.g., JP-A-57-77612), combined with synthetic polymers (e.g., JP-A-58-244), or the main component, rubber. Methods such as binding fibroin (Japanese Patent Publication No. 59-21339) may also be considered.
しかし、ながら、これらの技術には次のような欠点があ
った。However, these techniques had the following drawbacks.
すなわち、結晶化度を上げたフィブロインは、強度は大
きいが、伸びやしなやかさが小さい。 また、合成ポリ
マーと結合させると、フィブロインの生体親和性を得た
い場合、合成ポリマーの影響でそれが半減してしまう。That is, fibroin with increased crystallinity has high strength but low elongation and flexibility. Furthermore, when fibroin is combined with a synthetic polymer, the biocompatibility of fibroin is reduced by half due to the effect of the synthetic polymer.
攪拌などで結晶化させた場合、大部分が析出してしま
い収率が悪い。 plを3〜5にしたり、超音波処理し
たりするとフィブロインが変性してしまう。If it is crystallized by stirring, most of it will precipitate, resulting in poor yield. Fibroin is denatured when the pl is set to 3 to 5 or when subjected to ultrasonic treatment.
また、このようにして得られたフィブロイン成形物は、
β型結晶化分率が高いため、β型結晶化分率の低いもの
に比べて、分子のバッキングが密である。 従って、吸
水性、物質透過性等の特性も良くない。In addition, the fibroin molded product obtained in this way is
Since the β-type crystallization fraction is high, the molecular backing is denser than that of the one with a low β-type crystallization fraction. Therefore, properties such as water absorption and substance permeability are also not good.
〈発明の目的〉
したがって、本発明の目的は、上述した従来技術の欠点
を解消し、柔軟性、伸縮性にすぐれ、さらに生体親和性
にもすぐれたフィブロイン成形物およびその製造方法を
提供しようとするにある。<Object of the Invention> Therefore, the object of the present invention is to eliminate the drawbacks of the above-mentioned conventional techniques and provide a fibroin molded product with excellent flexibility, stretchability, and biocompatibility, and a method for producing the same. There is something to do.
〈発明の構成〉
従来はβ型結晶分率を向上させて水不溶化していたが、
β型結晶は分子のバッキングが密なので、膜として使用
した場合、水や溶質の透過性が低かった。 また、薬剤
担体として用いた場合、薬剤の入り込むスペースが少な
かった。<Structure of the invention> Conventionally, the β-type crystal fraction was increased to make it water insoluble.
β-type crystals have a dense molecular backing, so when used as a membrane, they have low permeability to water and solutes. Furthermore, when used as a drug carrier, there was less space for the drug to enter.
これに対して、架橋することによって、ランダムコイル
状態やα型結晶状態でも水不溶化できることを見い出し
本発明に至った。On the other hand, the present inventors have discovered that even a random coil state or an α-type crystal state can be rendered water insoluble by crosslinking, leading to the present invention.
本発明の第1の態様によれば、実質的にフィブロインよ
りなり、フィブロインが架橋剤で処理されているフィブ
ロイン成形物が提供される。According to a first aspect of the present invention, there is provided a fibroin molded article consisting essentially of fibroin, the fibroin being treated with a crosslinking agent.
本発明の第2の態様によれば、フィブロイン溶液に架橋
剤を添加したのち、フィブロインを固形化するフィブロ
イン成形物の製造方法が提供される。According to a second aspect of the present invention, there is provided a method for producing a fibroin molded article, which comprises adding a crosslinking agent to a fibroin solution and then solidifying the fibroin.
本発明の第3の態様によれば、フィブロイン溶液からフ
ィブロインを固形化成形したのち、架橋剤で処理するフ
ィブロイン成形物の製造方法が提供される。According to a third aspect of the present invention, there is provided a method for producing a fibroin molded article, which comprises solidifying and molding fibroin from a fibroin solution and then treating the product with a crosslinking agent.
上記発明において、架橋剤はカルボジイミドまたはグル
タールアルデヒドが好適である。In the above invention, the crosslinking agent is preferably carbodiimide or glutaraldehyde.
また、成形物の形態としては、キャストフィルム、再生
繊維、浸透膜、コート被膜、多孔質体、マイクロビーズ
など多様に適用することができる。Moreover, various forms of the molded product can be applied, such as cast film, recycled fibers, permeable membranes, coated films, porous bodies, and microbeads.
〈発明の具体的構成〉
以下に本発明のフィブロイン成形物およびその製造方法
について更に詳細に説明する。<Specific Structure of the Invention> The fibroin molded product of the present invention and the method for producing the same will be explained in more detail below.
まず、本発明のフィブロイン成形物の製造方法について
述べる。 本発明においてはまずフィブロインの水溶液
を得る。 フィブロイン水溶液の原料としては、まゆ、
生糸、まゆ屑、生糸屑、絹紡糸、副蚕糸などのフィブロ
イン源を用いる。 これらの原料を、常法に従いセリシ
ンを精練除去した後、例えば銅−アンモニア水溶液、水
酸化銅−エチレンジアミン水溶液、ロダン酸塩水溶液、
臭化リチウム水溶液、塩化カルシウム水溶液、硝酸カル
シウム溶液、あるいは硝酸マグネシウム水溶液等に溶解
し、水等に対して透析、脱塩することにより調製したフ
ィブロイン水溶液を得る。 このフィブロイン水溶液
は所望の濃度に調整することができる。First, the method for producing a fibroin molded article of the present invention will be described. In the present invention, first, an aqueous solution of fibroin is obtained. Raw materials for the fibroin aqueous solution include cocoon,
Fibroin sources such as raw silk, cocoon waste, raw silk waste, silk spinning, and secondary silk thread are used. After removing sericin by scouring these raw materials according to a conventional method, for example, a copper-ammonia aqueous solution, a copper hydroxide-ethylenediamine aqueous solution, a rhodanate aqueous solution,
Fibroin is dissolved in an aqueous lithium bromide solution, a calcium chloride solution, a calcium nitrate solution, or a magnesium nitrate aqueous solution, and then dialyzed against water or the like and desalted to obtain an aqueous fibroin solution. This aqueous fibroin solution can be adjusted to a desired concentration.
溶解時に、アルコール類を添加して、溶解性を上げても
よい。 またフィブロイン水溶液はゲル化したものでも
よい。During dissolution, alcohols may be added to increase solubility. Further, the fibroin aqueous solution may be a gelled one.
本発明においては、このようにして調製したフィブロイ
ン水溶液に対して適当量の架橋剤を添加してフィブロイ
ン間を架橋する。 この時の反応温度は変性などが生じ
ないよう室温で行うのが好ましい。 これにより水溶性
フィブロインを水不溶化するフィブロイン水溶液に適用
する架橋剤としては、1−エチル−3−(3−ジメチル
アミノプロピル)カルボジイミド塩酸塩(ウォーターソ
ルブルカルボジイミド:EDC)、グルタールアルデヒ
ド(GA)、エポキシ化合物、ビスイミデート類、ジア
ジド類、ジニトレン類、シバライド類、ジアルデヒド類
、シマレイミド類、ジイソシアネート類、ジェポキシ類
、ジスルホニルクロライド類、カルボジイミド類、イソ
オキサゾリウム塩類、ジ(1゜10−フェナントロリン
)銅、ジチオビス(スクシン−イミジルプロピオン酸)
、ウッドワード試薬などを用いることができる。 な
お、EDCは、塩酸酸の形で市販されているが、水中で
は解離してカルボジイミドの形でフィブロインと反応す
ると考えられる。In the present invention, an appropriate amount of crosslinking agent is added to the aqueous fibroin solution prepared in this way to crosslink the fibroin. The reaction temperature at this time is preferably room temperature to prevent denaturation. Examples of crosslinking agents to be applied to the fibroin aqueous solution that make water-soluble fibroin water-insoluble include 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (water-soluble carbodiimide: EDC), glutaraldehyde (GA) , epoxy compounds, bisimidates, diazides, dinitrenes, cybarides, dialdehydes, simalimides, diisocyanates, jepoxies, disulfonyl chlorides, carbodiimides, isoxazolium salts, di(1゜10-phenanthroline) ) Copper, dithiobis(succinimidylpropionic acid)
, Woodward reagent, etc. can be used. Na
EDC is commercially available in the form of hydrochloric acid, but it is thought to dissociate in water and react with fibroin in the form of carbodiimide.
このようにフィブロインを架橋反応させた後に所望形状
に成形する。After crosslinking the fibroin in this way, it is molded into a desired shape.
本発明の他の方法においては、上記のようにして調製さ
れたフィブロイン水溶液に架橋剤を添加することなく所
望の形状に成形した後に、いまだ結晶化度の低い水溶性
フィブロインを有する成形体に架橋剤を反応させてもよ
い。 これにより水溶性フィブロインを水不溶化する。In another method of the present invention, the aqueous fibroin solution prepared as described above is molded into a desired shape without adding a crosslinking agent, and then crosslinked to form a molded body containing water-soluble fibroin with a low degree of crystallinity. agent may be reacted. This makes the water-soluble fibroin water-insoluble.
この時用いられる架橋剤としては、ジイソシアネート、
ジェポキシ化合物などを用いることができる。The crosslinking agents used at this time include diisocyanate,
Jepoxy compounds and the like can be used.
以上述べたようにして得られた架橋された成形物に対し
て、低級アルコール処理、熱処理などを施してもよい。The crosslinked molded product obtained as described above may be subjected to lower alcohol treatment, heat treatment, etc.
目的によっては、フィブロインに予め化学修飾、添加
物混合などを施しておいてもよいし、成形物に対して化
学修飾、添加物抽出などを施してもよい。Depending on the purpose, the fibroin may be subjected to chemical modification, additive mixing, etc., or the molded product may be subjected to chemical modification, additive extraction, etc.
フィブロイン水溶液から成形した成形物は、アルコール
などの脱水剤、熱処理などの方法により乾燥させる。A molded article formed from an aqueous fibroin solution is dried using a dehydrating agent such as alcohol, heat treatment, or the like.
上述した方法あるいは他の種々の方法によって架橋処理
を施されたフィブロインは成形されるが、その用途、目
的などに応じて種々の形態の成形物とすることができる
。Fibroin that has been crosslinked by the above-mentioned method or various other methods is molded, and it can be molded into various shapes depending on its use, purpose, etc.
本発明の架橋処理されたフィブロイン成形物は後の実施
例にも示すように柔軟性、伸縮性にすぐれる。 また、
絹糸は縫合糸にも用いられるように元来生体親和性にも
すぐれており、本発明のフィブロイン成形物も生体親和
性にすぐれる。The crosslinked fibroin molded product of the present invention has excellent flexibility and elasticity, as shown in the examples below. Also,
Silk thread originally has excellent biocompatibility as it is also used for sutures, and the fibroin molded product of the present invention also has excellent biocompatibility.
成形物はその用途などに応じて種々の形態に加工するこ
とができる。The molded product can be processed into various forms depending on its use.
例えば成形物はフィルム状にすることができ、上記フィ
ブロイン水溶液からフィルム化するにはキャストによる
のが好適であるが、他の再生凝固などの方法を用いるこ
ともできる。For example, the molded product can be made into a film, and casting is preferred for forming the film from the aqueous fibroin solution, but other methods such as regeneration coagulation can also be used.
フィルム状フィブロイン成形物は、フィルター、センサ
ー膜などに用いることができる。The film-like fibroin molded product can be used for filters, sensor membranes, and the like.
また成形物は繊維状にすることができ、ブイプロイン水
溶液から繊維状にするには従来性われていたようにして
行うことができる。 これは縫合糸、人工血管、不織布
などに用いられる。Further, the molded product can be made into a fibrous form, and forming a fibrous form from an aqueous solution of buproin can be carried out in a conventional manner. This is used for sutures, artificial blood vessels, non-woven fabrics, etc.
また成形物は膜状にすることができる。 膜は浸透用、
他の基体の皮膜などに適用され、用途としては透析膜、
基体の生態適合性付加などがある。 他の基体への皮膜
形成法としては、塗布乾燥などがあげられる。Moreover, the molded product can be made into a film. The membrane is for osmosis;
It is applied to coatings on other substrates, and its uses include dialysis membranes,
This includes adding ecological compatibility to the substrate. Other methods for forming a film on a substrate include coating and drying.
また成形物は多孔質体、マイクロビーズ、ペレットなど
の塊状に加工することもできる。Moreover, the molded product can also be processed into a block shape such as a porous body, microbeads, or pellets.
多孔質化は発泡剤の添加、凍結乾燥などにより行うこと
ができ、マイクロビーズ化は乾燥粉砕などにより行うこ
とができる。 これらには薬剤などを担持させると徐放
性が改善される。Making it porous can be done by adding a foaming agent, freeze drying, etc., and making it into microbeads can be done by drying and pulverizing. When these drugs are loaded with drugs, sustained release properties are improved.
この他にも、吸着剤基材なとの用途がある。Other uses include adsorbent base materials.
本発明のフィブロイン成形物は架橋剤で処理されて不溶
化されβ型構造にはなっていないと考えられる。 ra
ndom coil、α型構造物では成形物にしても水
溶性があるために溶けてしまうが、本発明の架橋処理さ
れたフィブロイン成形物はrandom coil、α
型構造物が単に架橋されているだけでβ型構造化しては
いないため水に浸漬しても膨潤はするが溶けることはな
い。It is considered that the fibroin molded product of the present invention is treated with a crosslinking agent to be insolubilized and does not have a β-type structure. ra
Although a ndom coil, α-type structure melts even if it is made into a molded product because it is water-soluble, the crosslinked fibroin molded product of the present invention is a random coil, α-type structure.
Since the mold structure is simply cross-linked and does not have a β-type structure, it will swell but will not dissolve when immersed in water.
〈実施例〉
次に本発明を実施例および比較例をあげて具体的に説明
する。<Examples> Next, the present invention will be specifically described with reference to Examples and Comparative Examples.
(実施例1)
生糸を50倍量の0.5%炭酸ナトリウム水溶液中に入
れ、85〜90℃で20分間ゆっくり攪拌し、その後、
同量の水で2回洗浄し、さらに流水で洗浄し、セリシン
を除去した。(Example 1) Raw silk was placed in 50 times the amount of 0.5% sodium carbonate aqueous solution, slowly stirred at 85 to 90°C for 20 minutes, and then
The sericin was removed by washing twice with the same amount of water and then with running water.
この生糸をさらに、ベンゼン/メタノール=2/1の液
でソックスレー抽出を施し、ワックス、色素などを取除
いた。This raw silk was further subjected to Soxhlet extraction using a benzene/methanol ratio of 2/1 to remove wax, pigments, and the like.
このように精練された生糸3gを8 MLiBr水溶液
100叔中に浸し、37℃で48時間静置し、溶解させ
た。 この溶液をセルロース製透析チューブ中に入れ、
水に対して透析を行った。 透析液は1日3回交換し、
透析液に硝酸銀を溶かし、白濁しなくなるまで行った。3 g of the thus refined raw silk was immersed in 100 g of an 8 M LiBr aqueous solution and allowed to stand at 37° C. for 48 hours to dissolve. Place this solution in a cellulose dialysis tube,
Dialysis was performed against water. The dialysate was changed three times a day.
Silver nitrate was dissolved in the dialysate until it no longer became cloudy.
透析チューブごと取り出し、これに風を当てて風乾し
、フィブロイン水溶液を濃縮した。 さらに、約900
’OGで10分間遠心し、固形物を取除いた。 このフ
ィブロイン水溶液の濃度は1.5wt%であった。The entire dialysis tube was taken out and air-dried with air to concentrate the fibroin aqueous solution. Furthermore, about 900
Centrifuged in 'OG for 10 minutes to remove solids. The concentration of this fibroin aqueous solution was 1.5 wt%.
次に、液を2分し、一方に架橋剤としてペプチド合成試
薬1−エチル−3−(3−ジメチルアミノプロピル)カ
ルボジイミド塩酸塩(以下EDCという)をフィブロイ
ンと等1加え、溶解させた。EDCを加えたものを本発
明例1とし、EDCを加えなかったものを比較例1とす
る。Next, the liquid was divided into two parts, and one part of the peptide synthesis reagent 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (hereinafter referred to as EDC) as a crosslinking agent was added to one part along with fibroin and dissolved. The sample to which EDC was added is referred to as Invention Example 1, and the sample to which EDC was not added is referred to as Comparative Example 1.
両者をポリスチレン製シャーレに流延し、室温で3日間
乾燥させた。 シャーレ上にはフィブロインフィルム
が形成されており、両者とも容易にシャーレからはがす
ことができた。 両者の一部を切りとり、水中に投入す
ると、EDCを加えた方は、膨潤するが、溶解はしなか
った。 EDCを加えない方は容易に水に溶けた。Both were cast into a polystyrene Petri dish and dried at room temperature for 3 days. A fibroin film was formed on the Petri dish, and both could be easily peeled off from the Petri dish. When a portion of both was cut out and placed in water, the one to which EDC was added swelled but did not dissolve. The one without EDC was easily dissolved in water.
次に、両者をエタノール中に一晩浸漬し、乾燥させた。Next, both were soaked in ethanol overnight and dried.
再び両者の一部を切りとり、水中に投入すると、今度
は両者とも水には溶けなかった。When I cut out parts of both again and put them into water, this time neither of them dissolved in water.
次に両者の引張り試験を行った。 サンプルを長さ80
mm、幅10mm、厚さ0.04mmの大きさに切り
取り、東洋精機製のストログラフTにて、温度23℃、
初期長50mm、引張速度50 mm/minで破断強
度、破断伸度を測定した。Next, a tensile test was conducted on both. sample length 80
It was cut into pieces 10 mm wide and 0.04 mm thick, and heated at 23°C using Strograph T manufactured by Toyo Seiki.
The breaking strength and breaking elongation were measured at an initial length of 50 mm and a tensile speed of 50 mm/min.
その結果を下に記す。The results are shown below.
本発明例1 4.3X10’ 60比較例1
11.6X10’ 2このように、本発明例1は
比較例1と比べて強度は37%に低下しているにもかか
わらず伸びは30倍に達し、比較例1のものは剛直でも
ろいが、本発明例1のものは柔軟で伸びがよいのがわか
る。Invention example 1 4.3X10' 60 Comparative example 1
11.6X10' 2 In this way, although the strength of Inventive Example 1 is 37% lower than that of Comparative Example 1, the elongation is 30 times that of Comparative Example 1, whereas Comparative Example 1 is rigid and brittle. It can be seen that the material of Invention Example 1 is flexible and has good elongation.
〈発明の効果〉
本発明のフィブロイン成形物は、従来伸びやしなやかさ
のなかったフィブロイン成形物に比べて、30倍もの伸
びをもつものが得られ、本発明の製造法によればこのよ
うなフィブロイン成形物を簡単に得ることができる。<Effects of the Invention> The fibroin molded product of the present invention has 30 times more elongation than conventional fibroin molded products that lacked elongation and flexibility. Fibroin molded products can be easily obtained.
Claims (11)
架橋剤で処理されていることを特徴とするフィブロイン
成形物。(1) A fibroin molded article consisting essentially of fibroin, the fibroin being treated with a crosslinking agent.
囲第1項に記載のフィブロイン成形物。(2) The fibroin molded article according to claim 1, wherein the crosslinking agent is carbodiimide.
求の範囲第1項に記載のフィブロイン成形物。(3) The fibroin molded article according to claim 1, wherein the crosslinking agent is glutaraldehyde.
る特許請求の範囲第1項ないし第3項のいずれかに記載
のフィブロイン成形物。(4) The fibroin molded product according to any one of claims 1 to 3, wherein the fibroin molded product is a cast film.
求の範囲第1項ないし第3項のいずれかに記載のフィブ
ロイン成形物。(5) The fibroin molded product according to any one of claims 1 to 3, wherein the fibroin molded product is a recycled fiber.
の範囲第1項ないし第3項のいずれかに記載のフィブロ
イン成形物。(6) The fibroin molded product according to any one of claims 1 to 3, wherein the fibroin molded product is a permeable membrane.
請求の範囲第1項ないし第3項のいずれかに記載のフィ
ブロイン成形物。(7) The fibroin molded product according to any one of claims 1 to 3, wherein the fibroin molded product is a coat film.
求の範囲第1項ないし第3項のいずれかに記載のフィブ
ロイン成形物。(8) The fibroin molded product according to any one of claims 1 to 3, wherein the fibroin molded product is a porous body.
特許請求の範囲第1項ないし第3項のいずれかに記載の
フィブロイン成形物。(9) The fibroin molded product according to any one of claims 1 to 3, wherein the fibroin molded product is a microbead.
ィブロインを固形化することを特徴とするフィブロイン
成形物の製造方法。(10) A method for producing a fibroin molded article, which comprises adding a crosslinking agent to a fibroin solution and then solidifying the fibroin.
形したのち、架橋剤で処理することを特徴とするフィブ
ロイン成形物の製造方法。(11) A method for producing a fibroin molded product, which comprises solidifying and molding fibroin from a fibroin solution and then treating it with a crosslinking agent.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP27784387A JPH01118530A (en) | 1987-11-02 | 1987-11-02 | Molded item of fibroin and its preparation |
PCT/JP1988/001099 WO1989004339A1 (en) | 1987-11-02 | 1988-10-28 | Fibroin moldings, process for their preparation, heparin-immobilizing carrier, and process for its preparation |
EP19880909382 EP0352330A4 (en) | 1987-11-02 | 1988-10-28 | Fibroin moldings, process for their preparation, heparin-immobilizing carrier, and process for its preparation. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP27784387A JPH01118530A (en) | 1987-11-02 | 1987-11-02 | Molded item of fibroin and its preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH01118530A true JPH01118530A (en) | 1989-05-11 |
Family
ID=17589039
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP27784387A Pending JPH01118530A (en) | 1987-11-02 | 1987-11-02 | Molded item of fibroin and its preparation |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH01118530A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH09241399A (en) * | 1996-03-08 | 1997-09-16 | Fukushima Pref Gov | Method for preparing tussah fibroin film and preparation of toilet lotion containing tussah fibroin |
JP2009270208A (en) * | 2008-05-01 | 2009-11-19 | Ohara Palladium Kagaku Kk | Antibacterial deodorant processing agent for fiber and textile product processed with the processing agent |
JP2013129938A (en) * | 2011-12-21 | 2013-07-04 | Komatsu Seiren Co Ltd | Functional fiber fabric and method for producing the same |
-
1987
- 1987-11-02 JP JP27784387A patent/JPH01118530A/en active Pending
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH09241399A (en) * | 1996-03-08 | 1997-09-16 | Fukushima Pref Gov | Method for preparing tussah fibroin film and preparation of toilet lotion containing tussah fibroin |
JP2009270208A (en) * | 2008-05-01 | 2009-11-19 | Ohara Palladium Kagaku Kk | Antibacterial deodorant processing agent for fiber and textile product processed with the processing agent |
JP2013129938A (en) * | 2011-12-21 | 2013-07-04 | Komatsu Seiren Co Ltd | Functional fiber fabric and method for producing the same |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6316795B2 (en) | Novel collagen material and method for obtaining the same | |
EP0132979B1 (en) | Aqueous atelocollagen solution and method of preparing same | |
US6175053B1 (en) | Wound dressing material containing silk fibroin and sericin as main component and method for preparing same | |
US4349470A (en) | Protein polymer hydrogels | |
JP2520858B2 (en) | Collagen treatment method for facilitating crosslinking of collagen | |
WO2002096978A1 (en) | Crosslinked elastin and process for producing the same | |
JPH06508169A (en) | Water-insoluble derivatives of polyanionic polysaccharides | |
WO1987004078A1 (en) | Precipitation of collagen in tactoid form | |
US20130337227A1 (en) | Non-fibrogenesis collagen material and a manufacturing method thereof | |
JPS6229532A (en) | Antithrombogenetic medical material and production thereof | |
JPH02109570A (en) | Silkfibroin-containing molding | |
JP2955653B2 (en) | Silk protein / collagen composite and method for producing the same | |
JP2507885B2 (en) | Silk fibroin hydrogel | |
JPH01118530A (en) | Molded item of fibroin and its preparation | |
WO1989004339A1 (en) | Fibroin moldings, process for their preparation, heparin-immobilizing carrier, and process for its preparation | |
JPWO2003094985A1 (en) | Artificial extracellular matrix and method for producing the same | |
KR101282394B1 (en) | The covalent grafting of hydrophobic substances on collagen | |
JPH01119261A (en) | Heparin fixing carrier and its manufacture | |
RU2135214C1 (en) | Method of pre-implantation treatment of textile articles for cardiovascular surgery | |
JPH0622580B2 (en) | Medical material composed of succinyl chitosan | |
AU591964B2 (en) | Collagen products | |
JPS58121957A (en) | Anti-thromotic medical material | |
JPH0744951B2 (en) | Anticoagulant medical material | |
JPH01274767A (en) | Artificial skin material and its manufacture | |
JPH012652A (en) | medical tube |